The impact of an illness perception conversation on open-label placebo response in knee osteoarthritis: A randomised controlled trial

• DOI: 10.1016/j.joca.2024.07.005
• Publication Date: 2024-07-17T06:59:34Z
• Authors: Elisabeth Ginneru...; Tanja Schjødt Jør...; Camilla Dew-Hattens; Robin Christensen; Johannes Iuel Berg; Lene Vase; Anna Døssing; Sabrina Mai Nielsen; Lars Erik Kristensen; Henning Bliddal; Karen Ellegaard; Marius Henriksen
• Keywords: Randomised controlled trial; Open-label placebo; Illness perception; Knee osteoarthritis

To compare the effect of an illness perception conversation (IPC), relative to a research participation conversation (RPC), on 2-week changes in knee pain in patients with knee osteoarthritis.This was a randomised single-blind trial. Patients were randomised to two matched conversations. An IP conversation concerning the participant's knee pain-related illness perception (IP) or an RPC concerning the participant's motivation for participating in research. Both conversations were followed by an open-label intraarticular saline injection in the most symptomatic knee. The primary outcome was change in knee pain from baseline to 2 weeks follow-up on a 100 mm visual analogue scale (VAS). Key secondary outcomes included the Knee injury and Osteoarthritis Outcome Score (KOOS) subscales: Activities of daily living (ADL) and Quality of life (QoL). Main analyses were based on the intention-to-treat population using repeated measures mixed effects linear models.103 patients were randomised to the IPC group (n = 52) and the RPC group (n = 51). VAS knee pain scores changed statistically significantly from baseline to end of treatment in both groups, -13.7 (standard error [SE]: 3.2) in the IPC group and -13.0 (SE: 3.1) in the RPC group with an adjusted between-group difference of -0.7 (95% CI: -8.3 to 6.9; P = 0.85). Likewise, no group differences were seen in KOOS ADL and KOOS QoL.A conversation concerning knee pain-related IP did not augment the pain-relieving effect of an open-label placebo injection when compared to a similar control conversation concerning motivations for participating in research.NCT05225480.